Truist Securities Upgrades Sabra Health Care REIT to Buy, Maintains Price Target to $22

Benzinga Newsdesk www.benzinga.com Positive 56.2%

Neg 0% Neu 0% Pos 56.2%

Truist Securities analyst Michael Lewis upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Hold to Buy and maintains the price target from $22 to $22.